PE20000341A1 - Derivados de acido fenoxiacetico y de fenoximetil tetrazol que poseen propiedades antitumorales - Google Patents

Derivados de acido fenoxiacetico y de fenoximetil tetrazol que poseen propiedades antitumorales

Info

Publication number
PE20000341A1
PE20000341A1 PE1999000244A PE00024499A PE20000341A1 PE 20000341 A1 PE20000341 A1 PE 20000341A1 PE 1999000244 A PE1999000244 A PE 1999000244A PE 00024499 A PE00024499 A PE 00024499A PE 20000341 A1 PE20000341 A1 PE 20000341A1
Authority
PE
Peru
Prior art keywords
alkyl
phenoximethyl
tetrazole
derivatives
formula
Prior art date
Application number
PE1999000244A
Other languages
English (en)
Inventor
Roberto Di Domenico
Ernesto Menta
Silke Hansen
Brigitte Kaluza
Ralf Schumacher
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PE20000341A1 publication Critical patent/PE20000341A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/62Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by hydrogenation of carbon-to-carbon double or triple bonds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/72Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups
    • C07C45/74Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups combined with dehydration
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/82Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups
    • C07C49/83Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups polycyclic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/82Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups
    • C07C49/835Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups having unsaturation outside an aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/76Unsaturated compounds containing keto groups
    • C07C59/90Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/67Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
    • C07C69/708Ethers
    • C07C69/712Ethers the hydroxy group of the ester being etherified with a hydroxy compound having the hydroxy group bound to a carbon atom of a six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

SE REFIERE AL USO DE DERIVADOS DE ACIDO FENOXIACETICO Y DE FENOXIMETIL TETRAZOL DE FORMULA I, DONDE EL GRUPO -O-CR1R2-(CH2)p-A SE ENCUENTRA EN POSICION ORTO, META O PARA; A ES -COOH, -COO-ALQUILO C1-C4, -CN, GRUPO DE FORMULA a; R` ES H, ALQUILO C1-C4, EL GRUPO A-(CH2)p-CR1R2- ES FENILO, BENCILO, INDOLIL(METILO) OPCIONALMENTE SUSTITUIDO CON R4; p ES 0-2; R1 Y R2 SON H, ALQUILO C1-C8, CICLOALQUILO C3-C7; R4 ES CLORO, BROMO, IODO, ALQUILO C1-C8, HIDROXI, ALCOXI C1-C4, ACILO C1-C4, BENCIL SUSTITUIDO CON R4; n ES 1-4; m ES 0-1; B ES ALQUILO C1-C10, -CO-C(R3)(=CH)-R, -CO-CH(R3)-CH2-R; -CO-CH(R3)-CH2-NR5R6, CUANDO m ES 0; -CH=C(R3)-CO-Ar CUANDO m ES 1; R ES -Ar, -CO-Ar; R3 ES H, ALQUILO C1-C8; R5 Y R6 SON ALQUILO C1-C4, PIPERIDINO, PIPERAZINO, ALQUILPIPERAZINO C1-C8, MORFOLINO, TIOMORFOLINO; Ar ES FENILO OPCIONALMENTE SUSTITUIDO CON 1-3 CLORO, BROMO, IODO, ALCOXI C1-C4, ENTRE OTROS. TAMBIEN SE REFIERE A COMPUESTOS PREFERIDOS DE FORMULA A. EL COMPUESTO I POSEE ACTIVIDAD ANTAGONISTA DE LA PROTO-ONCOPROTEINA MDM2 (DOBLE MINUTO 2 DE RATA) AL INTERACTUAR CON p53 ACTIVA POR LO QUE PUEDE SER UTIL PARA EL TRATAMIENTO DE TUMORES, SARCOMA
PE1999000244A 1998-03-30 1999-03-26 Derivados de acido fenoxiacetico y de fenoximetil tetrazol que poseen propiedades antitumorales PE20000341A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98105726A EP0947511A1 (en) 1998-03-30 1998-03-30 Derivatives of phenoxy acetic acid and of phenoxymethyl tetrazole having antitumor activity

Publications (1)

Publication Number Publication Date
PE20000341A1 true PE20000341A1 (es) 2000-05-08

Family

ID=8231677

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1999000244A PE20000341A1 (es) 1998-03-30 1999-03-26 Derivados de acido fenoxiacetico y de fenoximetil tetrazol que poseen propiedades antitumorales

Country Status (20)

Country Link
EP (1) EP0947511A1 (es)
JP (1) JP2000063340A (es)
KR (1) KR19990078366A (es)
CN (1) CN1232028A (es)
AR (1) AR018170A1 (es)
AU (1) AU2250299A (es)
BR (1) BR9901208A (es)
CA (1) CA2267047A1 (es)
HR (1) HRP990093A2 (es)
HU (1) HUP9900804A3 (es)
ID (1) ID22335A (es)
IL (1) IL129191A0 (es)
MA (1) MA26616A1 (es)
NO (1) NO991526L (es)
NZ (1) NZ334874A (es)
PE (1) PE20000341A1 (es)
PL (1) PL332273A1 (es)
SG (1) SG81972A1 (es)
TR (1) TR199900719A2 (es)
ZA (1) ZA992407B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2841784B1 (fr) * 2002-07-08 2007-03-02 Composition a base de derives de 1,3-diphenylprop-2en-1-one substitues, preparation et utilisations
FR2841900B1 (fr) 2002-07-08 2007-03-02 Genfit S A Nouveaux derives de 1,3-diphenylprop-2-en-1-one substitues, preparation et utilisations
FR2857361B1 (fr) * 2003-07-08 2005-09-09 Genfit S A PREPARATION DE DERIVES DE 1,3-DIPHENYPROP-2-¼n-1-one
WO2005063774A1 (en) * 2003-12-22 2005-07-14 Johns Hopkins University Boronic acid aryl analogs
JP2007297283A (ja) * 2004-07-28 2007-11-15 Santen Pharmaceut Co Ltd 新規桂皮酸関連化合物
SG174107A1 (en) * 2006-08-30 2011-09-29 Univ Michigan New small molecule inhibitors of mdm2 and the uses thereof
DE602007006519D1 (de) 2006-09-21 2010-06-24 Hoffmann La Roche Oxindolderivate als antikrebsmittel
US7638548B2 (en) 2006-11-09 2009-12-29 Hoffmann-La Roche Inc. Spiroindolinone derivatives
US7553833B2 (en) 2007-05-17 2009-06-30 Hoffmann-La Roche Inc. 3,3-spiroindolinone derivatives
US7928233B2 (en) 2009-02-10 2011-04-19 Hoffmann-La Roche Inc. Spiroindolinone pyridine derivatives
US8217051B2 (en) 2009-02-17 2012-07-10 Hoffmann-La Roche Inc. Spiroindolinone derivatives
US8076482B2 (en) 2009-04-23 2011-12-13 Hoffmann-La Roche Inc. 3,3′-spiroindolinone derivatives
US8017607B2 (en) 2009-10-14 2011-09-13 Hoffmann-La Roche Inc. N-substituted-pyrrolidines as inhibitors of MDM2-P-53 interactions
US8088815B2 (en) 2009-12-02 2012-01-03 Hoffman-La Roche Inc. Spiroindolinone pyrrolidines
US8288431B2 (en) 2010-02-17 2012-10-16 Hoffmann-La Roche Inc. Substituted spiroindolinones
US8217044B2 (en) 2010-04-28 2012-07-10 Hoffmann-La Roche Inc. Spiroindolinone pyrrolidines

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3255241A (en) * 1961-01-19 1966-06-07 Merck & Co Inc (2-alkylidene acyl)phenoxy-and (2-alkylidene acyl)phenylmercaptocarboxylic acids
BE639727A (es) * 1962-11-13
US3251064A (en) * 1962-11-13 1966-05-10 Everett M Schultz beta-aminoacylphenoxy-and beta-aminoacylphenylmercapto-derivatives of monocarboxylicacids
US3994955A (en) * 1975-01-20 1976-11-30 G. D. Searle & Co. Substituted phenoxydialkylacetic acids and esters
US4904697A (en) * 1987-04-09 1990-02-27 Merrell Dow Pharmaceuticals Inc. Controlling the growth of certain tumor tissue with chalcone derivatives
JPH0624975A (ja) * 1992-05-12 1994-02-01 Dainippon Ink & Chem Inc 制癌活性増強剤
DE4327365A1 (de) * 1993-08-14 1995-02-16 Boehringer Mannheim Gmbh Verwendung von Phenolen und Phenolderivaten als Arzneimittel mit fibrinogensenkender Wirkung

Also Published As

Publication number Publication date
BR9901208A (pt) 2000-04-25
TR199900719A2 (xx) 1999-10-21
ID22335A (id) 1999-09-30
JP2000063340A (ja) 2000-02-29
SG81972A1 (en) 2001-07-24
CA2267047A1 (en) 1999-09-30
AR018170A1 (es) 2001-10-31
CN1232028A (zh) 1999-10-20
IL129191A0 (en) 2000-02-17
HUP9900804A3 (en) 2001-08-28
NO991526D0 (no) 1999-03-29
KR19990078366A (ko) 1999-10-25
AU2250299A (en) 1999-10-14
HUP9900804A2 (hu) 1999-11-29
EP0947511A1 (en) 1999-10-06
ZA992407B (en) 1999-09-30
PL332273A1 (en) 1999-10-11
HU9900804D0 (en) 1999-05-28
NZ334874A (en) 2000-08-25
HRP990093A2 (en) 2000-02-29
MA26616A1 (fr) 2004-12-20
NO991526L (no) 1999-10-01

Similar Documents

Publication Publication Date Title
PE20000341A1 (es) Derivados de acido fenoxiacetico y de fenoximetil tetrazol que poseen propiedades antitumorales
PE133999A1 (es) Derivados de acido hidroxamico como inhibidores de metaloproteasas de matriz (mmp)
DK0928788T3 (da) Imidazolidin-4-on-derivater, der er nyttige som anticancer-midler
DK519985D0 (da) Quinoloncarboxylsyrederivater, fremgangsmaade til fremstilling deraf og antibakterielt middel indeholdende saadanne derivater
DK0453042T3 (da) Hidtil ukendte 2 9-disubstituerede 4H-pyhrido[1 2-a]pyridin-4-oner
FI860369A0 (fi) Imidazolderivat, deras framstaellning och anvaendning samt dessa derivat innehaollande farmaceutiska kompositioner.
ATE199253T1 (de) Antidepressiv wirkende 3-halophenylpiperazinyl- propylderivate von substituierten triazolonen und triazoldionen
NO20000737L (no) Tetrahydro <gamma>-karboliner
ATE81458T1 (de) Bakterizide pharmazeutische zusammensetzung.
NZ221699A (en) Pyridazinone derivatives; pharmaceutical compositions and intermediates
GB1514776A (en) Compositions containing oxamic acid derivatives
ES8205770A1 (es) Procedimiento para la preparacion de derivados de 2,3-indo- lediona
ATE39692T1 (de) Phenylalkansaeure-derivate.
ATE63541T1 (de) N-phenylethylaminoalkyl-benzamide als antiarrhythmische mittel.
DK0397031T3 (da) Hidtil ukendte phenylalkansyreestere
HUT48586A (en) Process for production of derivatives of 1,4-disubstituated piperidinil and medical preparatives containing these substances
ES8707951A1 (es) Derivados de tetrazol
DE69110219T2 (de) 3-(1H-Indazol-3-yl)-4-pyridiname, Verfahren und Zwischenprodukte zu ihrer Herstellung und ihre Verwendung als Arzneimittel.
GR70356B (es)
ES2014975B3 (es) Nuevas 1,4 iento para su obtencion, asi como su utilizacion como medicamentos.
ES556048A0 (es) Un procedimiento para la preparacion de un derivado de tiazolidina.
NO165593C (no) Analogifremgangsmaate ved fremstilling av nye tetracykliske indolderivater.
DK382588D0 (da) Anti-psykotiske sammensaetninger indeholdende dioxopiperidin derivater
IL61695A (en) 2-(2,6-dihalophenyl-amino)-and 2-(2-fluoro-6-trifluoromethyl-phenyl-amino)-2-imidazoline derivatives,their preparation and pharmaceutical compositions containing them
ES8405361A1 (es) Procedimiento para preparar alquenamidas y fenilalquenamidas n,n-disubstituidas.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal